Kinyanjui, Timothy
46  results:
Search for persons X
?
10

Scabies in residential care homes: modelling, inference and..:

Kinyanjui, Timothy ; Middleton, Jo ; Güttel, Stefan...
http://sro.sussex.ac.uk/id/eprint/73765/3/Kinyanjui%20Middleton%20Gutell%20et%20al%202018%20Scabies%20in%20RNCs-%20Modelling%20inference%20and%20interventions.pdf.  , 2018
 
?
12

Model evaluation of target product profiles of an infant va..:

Kinyanjui, Timothy Muiruri ; Pan-Ngum, Wirichada ; Saralamba, Sompob..
Kinyanjui , T M , Pan-Ngum , W , Saralamba , S , Taylor , S & Nokes , D J 2020 , ' Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting ' , Vaccine . https://doi.org/10.1016/j.jvacx.2020.100055.  , 2020
 
?
13

Scabies in residential care homes: Modelling, inference and..:

Kinyanjui, Timothy Muiruri ; Middleton, Jo ; Güttel, Stefan...
Kinyanjui , T M , Middleton , J , Güttel , S , Cassell , J , Ross , J & House , T 2018 , ' Scabies in residential care homes: Modelling, inference and interventions for well-connected population sub-units ' , PL o S Computational Biology . https://doi.org/10.1371/journal.pcbi.1006046.  , 2018
 
?
14

Defining the vaccination window for respiratory syncytial v..:

Nyiro, Joyce U ; Kombe, Ivy K ; Sande, Charles J...
Nyiro , J U , Kombe , I K , Sande , C J , Kipkoech , J , Kiyuka , P K , Onyango , C O , Munywoki , P K , Kinyanjui , T M & Nokes , D J 2017 , ' Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya ' , PLoS ONE , vol. 12 , no. 5 , e0177803 . https://doi.org/10.1371/journal.pone.0177803.  , 2017
 
?
15

Predicting the relative impacts of maternal and neonatal re..:

Kinyanjui, Timothy Muiruri
Kinyanjui , T M 2017 , ' Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach. ' , Vaccine , vol. 35 , no. 2 , pp. 403-409 . https://doi.org/10.1016/j.vaccine.2016.10.073.  , 2017
 
1-15